Works matching DE "NUCLEOSIDE transport proteins"


Results: 197
    1
    2

    A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter‐Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.

    Published in:
    Chemistry - A European Journal, 2024, v. 30, n. 50, p. 1, doi. 10.1002/chem.202401327
    By:
    • Vrettos, Eirinaios Ι.;
    • Kyrkou, Stavroula G.;
    • Zoi, Vasiliki;
    • Giannakopoulou, Maria;
    • Chatziathanasiadou, Maria V.;
    • Kanaki, Zoi;
    • Agalou, Adamantia;
    • Bistas, Vasileios‐Panagiotis;
    • Kougioumtzi, Anastasia;
    • Karampelas, Theodoros;
    • Diamantis, Dimitrios A.;
    • Murphy, Carol;
    • Beis, Dimitris;
    • Klinakis, Apostolos;
    • Tamvakopoulos, Constantin;
    • Kyritsis, Athanasios P.;
    • Alexiou, George A.;
    • Tzakos, Andreas G.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Rheumatological manifestations of H syndrome.

    Published in:
    Rheumatology / Reumatologia, 2024, v. 62, n. 4, p. 294, doi. 10.5114/reum/191751
    By:
    • Honsali, Rahma;
    • Tahiri, Latifa;
    • Cherkaoui-Dekkaki, Sara;
    • Allali, Fadoua
    Publication type:
    Article
    9
    10
    11
    12

    Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

    Published in:
    Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1274692
    By:
    • Boyd, Lenka N. C.;
    • Nooijen, Lynn E.;
    • Ali, Mahsoem;
    • Puik, Jisce R.;
    • Moustaquim, Jasmine;
    • Rodrigues, Stephanie M. Fraga;
    • Broos, Robert;
    • Belkouz, Ali;
    • Meijer, Laura L.;
    • Le Large, Tessa Y. S.;
    • Erdmann, Joris I.;
    • Hooijer, Gerrit K. J.;
    • Heger, Michal;
    • Van Laarhoven, Hanneke W. M.;
    • Roos, Eva;
    • Kazemier, Geert;
    • Giovannetti, Elisa;
    • Verheij, Joanne;
    • Klümpen, Heinz-Josef
    Publication type:
    Article
    13

    Purinergic Signaling in Pulmonary Inflammation.

    Published in:
    Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01633
    By:
    • Le, Thanh-Thuy T.;
    • Berg, Nathaniel K.;
    • Harting, Matthew T.;
    • Li, Xiangyun;
    • Eltzschig, Holger K.;
    • Yuan, Xiaoyi
    Publication type:
    Article
    14

    Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38789-8
    By:
    • Persaud, Avinash K.;
    • Bernier, Matthew C.;
    • Massey, Michael A.;
    • Agrawal, Shipra;
    • Kaur, Tejinder;
    • Nayak, Debasis;
    • Xie, Zhiliang;
    • Weadick, Brenna;
    • Raj, Ruchika;
    • Hill, Kasey;
    • Abbott, Nicole;
    • Joshi, Arnav;
    • Anabtawi, Nadeen;
    • Bryant, Claire;
    • Somogyi, Arpad;
    • Cruz-Monserrate, Zobeida;
    • Amari, Foued;
    • Coppola, Vincenzo;
    • Sparreboom, Alex;
    • Bakfer, Sharyn D.
    Publication type:
    Article
    15

    The H syndrome.

    Published in:
    2015
    By:
    • Mehta, Sharad;
    • Masatkar, Vaishali;
    • Mittal, Asit;
    • Khare, Ashok K.;
    • Gupta, Lalit K.
    Publication type:
    Case Study
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    FSCPX, a Chemical Widely Used as an Irreversible A<sub>1</sub> Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.

    Published in:
    Molecules, 2018, v. 23, n. 9, p. 2186, doi. 10.3390/molecules23092186
    By:
    • Erdei, Tamas;
    • Szabo, Adrienn Monika;
    • Lampe, Nora;
    • Szabo, Katalin;
    • Kiss, Rita;
    • Zsuga, Judit;
    • Papp, Csaba;
    • Pinter, Akos;
    • Szentmiklosi, Andras Jozsef;
    • Szilvassy, Zoltan;
    • Juhasz, Bela;
    • Gesztelyi, Rudolf
    Publication type:
    Article
    28
    29
    30
    31

    H syndrome caused by a novel P324S mutation in SLC29A3 gene.

    Published in:
    International Journal of Dermatology, 2023, v. 62, n. 3, p. e138, doi. 10.1111/ijd.16264
    By:
    • Bhandari, Molisha;
    • Khullar, Geeti;
    • Batra, Satyendra;
    • Garg, Arpit;
    • Khunger, Niti;
    • Verma, Prashant;
    • Singh, Amitabh;
    • Misra, Ritu;
    • Yadav, Amit Kumar
    Publication type:
    Article
    32
    33
    34

    A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 9, p. 2114, doi. 10.3109/10428194.2013.867489
    By:
    • Rizzieri, David;
    • Vey, Norbert;
    • Thomas, Xavier;
    • Huguet-Rigal, Françoise;
    • Schlenk, Richard F.;
    • Krauter, Jürgen;
    • Kindler, Thomas;
    • Gjertsen, Bjørn Tore;
    • Blau, Igor Wolfgang;
    • Jacobsen, Tove Flem;
    • Johansen, Malin;
    • Bergeland, Trygve;
    • Gianella-Borradori, Athos;
    • Krug, Utz
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

    Published in:
    Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0248-4
    By:
    • Tavano, Francesca;
    • Fontana, Andrea;
    • Pellegrini, Fabio;
    • Burbaci, Francesca Paola;
    • Rappa, Francesca;
    • Cappello, Francesco;
    • Copetti, Massimiliano;
    • Maiello, Evaristo;
    • Lombardi, Lucia;
    • Graziano, Paolo;
    • Vinciguerra, Manlio;
    • di Mola, Fabio Francesco;
    • di Sebastiano, Pierluigi;
    • Andriulli, Angelo;
    • Pazienza, Valerio
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54914-7
    By:
    • Wright, Nicholas J.;
    • Matsuoka, Yutaka;
    • Park, Hyeri;
    • He, Wei;
    • Webster, Caroline G.;
    • Furutani, Kenta;
    • Fedor, Justin G.;
    • McGinnis, Aidan;
    • Zhao, Yiquan;
    • Chen, Ouyang;
    • Bang, Sangsu;
    • Fan, Ping;
    • Spasojevic, Ivan;
    • Hong, Jiyong;
    • Ji, Ru-Rong;
    • Lee, Seok-Yong
    Publication type:
    Article
    48
    49
    50